Study shows immunotherapy may benefit a subset of patients with penile cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPenile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typical

Oncology January 22,2024

Study shows immunotherapy may benefit a subset of patients with penile cancer

byDana-Farber Cancer InstituteCredit: Unsplash/CC0 Public DomainPenile cancer is a rare disease with approximately 2,070 new cases each year in the U.S. Treatment options are limited and typical

Oncology January 22,2024

Scientists create powerful, most-accurate tools to research deadliest blood cancer, study says

byThe Mount Sinai HospitalCredit: CC0 Public DomainTisch Cancer Center scientists have developed unique models of the deadliest blood cancer, acute myeloid leukemia (AML), creating a transformat

Oncology January 22,2024

Scientists create powerful, most-accurate tools to research deadliest blood cancer, study says

byThe Mount Sinai HospitalCredit: CC0 Public DomainTisch Cancer Center scientists have developed unique models of the deadliest blood cancer, acute myeloid leukemia (AML), creating a transformat

Oncology January 22,2024

Study reveals aggressive prostate cancer linked to ancestral heritage

byUniversity of SydneyCredit:Nature(2022). DOI: 10.1038/s41586-022-05154-6Two pioneering studies published simultaneously today inNatureandGenome Medicine, have ide

Oncology January 22,2024

Study reveals aggressive prostate cancer linked to ancestral heritage

byUniversity of SydneyCredit:Nature(2022). DOI: 10.1038/s41586-022-05154-6Two pioneering studies published simultaneously today inNatureandGenome Medicine, have ide

Oncology January 22,2024

Study shows novel agent can overcome immune dysfunction in cancer

by Roswell Park Comprehensive Cancer CenterVSSP restores myeloid cell frequencies following leukopenia. C57BL/6 mice were injected with CY (200 mg/kg body weight, i.p.) and with two consecutive daily

Oncology January 22,2024

Study shows novel agent can overcome immune dysfunction in cancer

by Roswell Park Comprehensive Cancer CenterVSSP restores myeloid cell frequencies following leukopenia. C57BL/6 mice were injected with CY (200 mg/kg body weight, i.p.) and with two consecutive daily

Oncology January 22,2024

Research illuminates a therapeutic strategy to induce cancer cell death

by Rachel Sauer,CU Anschutz Medical CampusCredit: CC0 Public DomainCancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors a

Oncology January 22,2024

Research illuminates a therapeutic strategy to induce cancer cell death

by Rachel Sauer,CU Anschutz Medical CampusCredit: CC0 Public DomainCancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumor suppressors a

Oncology January 22,2024

Study shows how morphine may contribute to bone loss and cancer-induced bone pain

by Stacy Pigott,University of ArizonaOn the left, cells isolated from breast cancer cells were treated with RANKL, a growth factor that stimulates bone resorption, to produce osteoclasts (pink).

Oncology January 22,2024

Study shows how morphine may contribute to bone loss and cancer-induced bone pain

by Stacy Pigott,University of ArizonaOn the left, cells isolated from breast cancer cells were treated with RANKL, a growth factor that stimulates bone resorption, to produce osteoclasts (pink).

Oncology January 22,2024

Research shows that lymph node sampling during kidney tumor surgery is safe

by Rachel Sauer,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainA longstanding approach to surgeries for children with kidney tumors has been an abundance of caution.While a growing b

Oncology January 22,2024

Research shows that lymph node sampling during kidney tumor surgery is safe

by Rachel Sauer,CU Anschutz Medical CampusCredit: Pixabay/CC0 Public DomainA longstanding approach to surgeries for children with kidney tumors has been an abundance of caution.While a growing b

Oncology January 22,2024

Study suggests chromosomal errors may hinder some aggressive tumors

by Julie Vera,Mayo ClinicGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.100937Chromosomal errors are a hallmark of cancer cells. Defects in the geno

Oncology January 22,2024

Study suggests chromosomal errors may hinder some aggressive tumors

by Julie Vera,Mayo ClinicGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.100937Chromosomal errors are a hallmark of cancer cells. Defects in the geno

Oncology January 22,2024

Study links reconstructive surgery after breast cancer to changes in upper limb movement

byUniversity of SaskatchewanCredit: Unsplash/CC0 Public DomainA recently published study authored by a pair of University of Saskatchewan (USask) researchers shows that reconstructive surgery af

Oncology January 22,2024

Study links reconstructive surgery after breast cancer to changes in upper limb movement

byUniversity of SaskatchewanCredit: Unsplash/CC0 Public DomainA recently published study authored by a pair of University of Saskatchewan (USask) researchers shows that reconstructive surgery af

Oncology January 22,2024

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Oncology January 22,2024

Research tests cost-effective approach to early-cancer detection from cell-free DNA in blood samples

byUniversity of California, Los AngelesCredit: Pixabay/CC0 Public DomainEarly detection remains key to successfully treating many cancers, and early detection via cell-free DNA (cfDNA) circulati

Oncology January 22,2024